✦ LIBER ✦

A systematic review highlights threats to validity in studies of barriers to cancer trial participation

✍ Scribed by Debra Fayter; Catriona McDaid; Alison Eastwood

Book ID: 116623115
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 404 KB
Volume: 60
Category: Article
ISSN: 0895-4356
DOI: 10.1016/j.jclinepi.2006.12.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Barriers to Participation in Randomised

Barriers to Participation in Randomised Controlled Trials: A Systematic Review

✍ Sue Ross; Adrian Grant; Carl Counsell; William Gillespie; Ian Russell; Robin Pre 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Barriers to participation in HIV drug tr

Barriers to participation in HIV drug trials: a systematic review

✍ Edward Mills; Kumanan Wilson; Beth Rachlis; Lauren Griffith; Ping Wu; Gordon Guy 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 93 KB

Barriers to participation in clinical tr

Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors

✍ Edward J Mills; Dugald Seely; Beth Rachlis; Lauren Griffith; Ping Wu; Kumanan Wi 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 118 KB

Obstacles to participation in randomised

Obstacles to participation in randomised cancer clinical trials: A systematic review of the literature

✍ Melissa M Grand; Peter C O'Brien 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 616 KB

Removing barriers to participation in cl

Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study

✍ Norma F Kanarek, Marty S Kanarek, Dare Olatoye, Michael A Carducci 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 260 KB

Barriers to the participation of African

Barriers to the participation of African-American patients with cancer in clinical trials : A pilot study

✍ Anjali S. Advani; Benjamin Atkeson; Carrie L. Brown; Bercedis L. Peterson; Laura 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Background: African-american patients have been under-represented in oncology clinical trials. better understanding barriers to african-american participation may help increase the accrual of african-american patients onto clinical trials. ## Methods: Two hundred eighteen patients with maligna